Can Finland compete as Europe’s start-up capi...

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

In this episode of The Perfect Pitch Podcast, we sit down with Mikael Hajjar and Hisham Halbouny, Managing Partners at P1 Ventures, to uncover the secrets of scaling startups in Africa. Mika and Hisham share their unique insights into why ...

Greg interviews Eric Ries, author of "The Lean Startup" and founder of The Long Term Stock Exchange.They talk about how to test business ideas, why businesses with a social mission will outperform, and opportunities in AI.►►Subscribe to Greg's weekly newsletter for insights on co ...  Show more

Europe’s tech scene is often seen as trailing the US and China but startups across the continent are challenging that perspective. We meet two founders that are shaking up the industry and proving that ambition, collaboration and smart risks can make Europe competitive again.  Se ...  Show more

Walid Mansour is the Co-Founder and Co-CEO of Middle East Venture Partners (MEVP) — one of the leading venture capital firms in the MENA region. With over a decade of experience in investing, Walid didn’t just invest in successful startups — he played a key role in building some ...  Show more